A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration
Clinical trial NCT03249740 · COMPLETED
Trial details
- NCT number
- NCT03249740
- Sponsor
- Graybug Vision
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-29
- Primary completion
- 2018-09-13
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.